WKC · World Kinect Corp

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $35.08 to $35.80, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $39.23 to $39.70, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $39.82 to $39.97, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $39.75 to $40.21, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

Shares are held by the Boitz Stebbins Irrevocable Family Trust, of which the reporting person is the trustee and a beneficiary. The reporting person disclaims beneficial ownership of any shares in which he does not have a pecuniary interest.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $35.00 to $35.18, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $32.9050 to $33.57, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

Includes 19,997 shares previously reported as held directly by the Reporting Person and which were transferred to the Boitz Stebbins Irrevocable Family Trust (the "Irrevocable Trust") for estate planning purposes.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

These shares were issued as a restricted stock unit grant to the reporting person by the issuer.

The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $30.00 to $30.33, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $28.83 to $29.36, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $26.97 to $27.055, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

803 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

933 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

1,574 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

833 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

1,710 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

1,471 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

1,115 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

1,388 restricted stock units held by the reporting person vested and settled on May 10, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on May 8, 2026.

These restricted stock units will vest in four equal annual installments beginning on May 10, 2027.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $27.58 to $27.765, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 24, 2025.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $26.47 to $27.26, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $27.50 to $27.58, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 24, 2025.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $27.305 to $28.29, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

Includes 1, 340 shares previously reported as held indirectly by the Reporting Person's spouse which were transferred to the Reporting Person for estate planning purposes.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $28.30 to $29.26, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

22,684 restricted stock units held by the reporting person vested and settled on March 28, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price of the issuer's common stock on the NYSE on March 27, 2026.

7,814 restricted stock units held by the reporting person vested and settled on March 28, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price of the issuer's common stock on the NYSE on March 27, 2026.

7,814 restricted stock units held by the reporting person vested and settled on March 28, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price of the issuer's common stock on the NYSE on March 27, 2026.

21,459 restricted stock units held by the reporting person vested and settled on March 15, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price of the issuer's common stock on the NYSE on March 13, 2026.

These restricted stock units will vest in three equal installments beginning on March 15, 2027.

8,622 restricted stock units held by the reporting person vested and settled on March 15, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price of the issuer's common stock on the NYSE on March 13, 2026.

7,391 restricted stock units held by the reporting person vested and settled on March 15, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price of the issuer's common stock on the NYSE on March 13, 2026.

These restricted stock units will vest in three equal installments beginning on March 15, 2027.

25,032 restricted stock units held by the reporting person vested and settled on March 15, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price of the issuer's common stock on the NYSE on March 13, 2026.

7,391 restricted stock units held by the reporting person vested and settled on March 15, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on March 13, 2026.

These restricted stock units will vest in three equal installments beginning on March 15, 2027.

8,622 restricted stock units held by the reporting person vested and settled on March 15, 2026. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on March 13, 2026.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.

The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $25.00 to $25.07, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.

802 restricted stock units held by the reporting person vested and settled on November 10, 2025. The issuer withheld the reported shares to cover the reporting person's tax liability associated with these restricted stock units.

The price shown is the closing price for the issuer's common stock on the NYSE on November 10, 2025.